文献速递肝病

人及实验性非酒精性脂肪性肝病中脂多糖肝脏定位增加

Increased Liver Localization of Lipopolysaccharides in Human and Experimental NAFLD.
PubMed 文献 · Hepatology · 2020-05-22

该研究在活检确诊的非酒精性脂肪性肝病(NAFLD)患者(25例单纯性脂肪变性、25例非酒精性脂肪性肝炎)及饮食诱导NASH小鼠中,检测大肠杆菌脂多糖(LPS)的血清水平与肝细胞定位。NASH患者血清LPS及肝细胞LPS定位高于对照,且与血清连蛋白和磷酸化核因子-κB表达相关;TLR4阳性巨噬细胞和血小板增多并与血清LPS相关。小鼠中LPS升高伴随NF-κB激活,TLR4抑制剂减轻肝脏炎症,阿司匹林减少纤维化。结论提示LPS可能通过TLR4通路激活巨噬细胞和血小板加重肝损伤。

要点

  • NASH患者血清LPS及肝细胞LPS定位高于对照,与血清连蛋白和磷酸化NF-κB表达相关。
  • NASH肝组织中TLR4阳性巨噬细胞和CD61阳性血小板增多,且与血清LPS值相关。
  • 小鼠NASH中LPS升高伴NF-κB激活,TLR4抑制剂减轻肝脏炎症,阿司匹林减少纤维化。

核心结论

  • 在NAFLD中,大肠杆菌LPS可能通过TLR4通路诱导巨噬细胞和血小板活化而加重肝损伤。

研究设计与样本

  • 研究纳入活检确诊的NAFLD患者25例单纯性脂肪变性(NAFL)和25例非酒精性脂肪性肝炎(NASH),并采用饮食诱导NASH小鼠模型。

主要发现

  • NASH患者血清LPS和肝细胞LPS定位高于对照,且与血清连蛋白和磷酸化核因子-κB表达相关。
  • NASH患者TLR4阳性巨噬细胞高于单纯性脂肪变性或对照,并与血清LPS相关。
  • NASH活检中CD61阳性血小板增多,多数为TLR4阳性,且TLR4阳性血小板与血清LPS值相关。
  • NASH小鼠血清LPS水平和肝细胞LPS定位较对照升高,并与核因子-κB激活相关。
  • NASH小鼠中,阿司匹林组较未治疗组纤维化程度更低;TLR4抑制剂治疗使肝脏炎症减轻。

临床怎么用

  • 在NAFLD患者中可关注血清LPS、连蛋白及TLR4通路活化作为肝脏炎症的潜在关联指标。
  • 动物实验提示TLR4抑制剂可能减轻NASH肝脏炎症,阿司匹林可能减少纤维化,但尚未在患者中验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Lipopolysaccharides (LPS) is increased in nonalcoholic fatty liver disease (NAFLD), but its relationship with liver inflammation is not defined. APPROACH AND RESULTS: We studied Escherichia coli LPS in patients with biopsy-proven NAFLD, 25 simple steatosis (nonalcoholic fatty liver) and 25 nonalcoholic steatohepatitis (NASH), and in mice with diet-induced NASH. NASH patients had higher serum LPS and hepatocytes LPS localization than controls, which was correlated with serum zonulin and phosphorylated nuclear factor-κB expression. Toll-like receptor 4 positive (TLR4+ ) macrophages were higher in NASH than simple steatosis or controls and correlated with serum LPS. NASH biopsies showed a higher CD61+ platelets, and most of them were TLR4+ . TLR4+ platelets correlated with serum LPS values. In mice with NASH, LPS serum levels and LPS hepatocyte localization were increased compared with control mice and associated with nuclear factor-κB activation. Mice on aspirin developed lower fibrosis and extent compared with untreated ones. Treatment with TLR4 inhibitor resulted in lower liver inflammation in mice with NASH. CONCLUSIONS: In NAFLD, Escherichia coli LPS may increase liver damage by inducing macrophage and platelet activation through the TLR4 pathway.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Carpino G, Del Ben M, Pastori D, et al. Increased Liver Localization of Lipopolysaccharides in Human and Experimental NAFLD. Hepatology. 2020. PMID: 31808577. doi:10.1002/hep.31056

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。